Cargando…
Therapeutic and prognostic potential of GPCRs in prostate cancer from multi-omics landscape
Prostate cancer (PRAD) is a common and fatal malignancy. It is difficult to manage clinically due to drug resistance and poor prognosis, thus creating an urgent need for novel therapeutic targets and prognostic biomarkers. Although G protein-coupled receptors (GPCRs) have been most attractive for dr...
Autores principales: | Li, Shiqi, Chen, Jianfang, Chen, Xin, Yu, Jin, Guo, Yanzhi, Li, Menglong, Pu, Xuemei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468875/ https://www.ncbi.nlm.nih.gov/pubmed/36110544 http://dx.doi.org/10.3389/fphar.2022.997664 |
Ejemplares similares
-
Prediction of Synergistic Drug Combinations for Prostate Cancer by Transcriptomic and Network Characteristics
por: Li, Shiqi, et al.
Publicado: (2021) -
Advancements in therapeutically targeting orphan GPCRs
por: Stockert, Jennifer A., et al.
Publicado: (2015) -
A new molecular subclassification and in silico predictions for diagnosis and prognosis of papillary thyroid cancer by alternative splicing profile
por: Li, Haiyan, et al.
Publicado: (2023) -
The therapeutic potential of orphan GPCRs, GPR35 and GPR55
por: Shore, Derek M., et al.
Publicado: (2015) -
Probing the Druggablility on the Interface of the Protein–Protein Interaction and Its Allosteric Regulation Mechanism on the Drug Screening for the CXCR4 Homodimer
por: Shen, Liting, et al.
Publicado: (2019)